No Data
Boji Medical Technology (300404.SZ): has been identified as a national level specialized, special and new "little giant" enterprise.
Gelonghui November 4th | Boji Medical Technology (300404.SZ) announced that recently, Boji Medical Technology Co., Ltd. received the specialized, special and new "Little Giant" enterprise certificate issued by the Ministry of Industry and Information Technology. The validity period of this specialized, special and new "Little Giant" enterprise is 3 years (July 1, 2024 - June 30, 2027).
Boji Medical Technology (300404.SZ) shareholders Zhao Lingli and Fermi No. 13 completed shareholding, totaling a 1.5% reduction in shares.
boji medical technology (300404.SZ) announced that the company has received the unanimous consent of the controlling shareholder and actual controller, Mr. Wang Tingchun...
boji medical technology (300404.SZ): Currently, the company has no research projects on anti-aging drugs.
According to Gelonhui on October 31, boji medical technology (300404.SZ) stated on the investor interaction platform that the company currently has no research projects on anti-aging drugs.
Broge Pharmaceuticals: Report for the third quarter of 2024
Boji Medical Technology (300404.SZ) released its performance for the first three quarters, with a net income of 43.2778 million yuan, an 87.98% year-on-year increase.
Boji Medical Technology (300404.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching...
Boji Medical Technology (300404.SZ): The net income for the first three quarters was 43.2778 million yuan, a year-on-year increase of 87.98%.
Boji Medical Technology (stock code: 300404.SZ) announced its third quarter report for the year 2024 on October 25th. The company achieved a revenue of 0.556 billion yuan in the first three quarters, an increase of 55.01% year-on-year; the net income attributable to shareholders of the listed company was 43.2778 million yuan, an increase of 87.98% year-on-year; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 34.8898 million yuan, an increase of 155.65% year-on-year; and the basic earnings per share was 0.1133 yuan.
Market Cool On Boji Medical Technology Co., Ltd.'s (SZSE:300404) Revenues Pushing Shares 25% LowerNo Data
No Data
